About Us
Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world.
It is Kardigan’s mission to develop multiple targeted treatments in parallel that bring people with cardiovascular diseases to the cures they deserve.
Led by Tassos Giannakakos, Jay Edelberg, M.D., Ph.D., and Bob McDowell, Ph.D., Kardigan’s co-founders have reunited after leading MyoKardia to discover and develop mavacamten, the first cardiac myosin inhibitor, resulting in an acquisition by Bristol Myers Squibb in 2020.
We have a cutting-edge discovery and translational research platform, a pipeline of late-stage candidates, and an industry-leading team that is driven to improve the lives of patients.
At Kardigan, we are motivated by our values which guide how we work, interact, and achieve our goals. Driven by patients and their families, we are deeply committed to improving the lives of patients and prioritizing their needs above all else. We believe in being authentic—leading with truth to bring out the best in others by creating an environment where every person knows they will be fully accepted. With an eagerness to learn, we encourage the highest levels of curiosity and are open to changing our minds. We are committed to winning as a team with urgency, excellence, and intention, and support each other no matter what role we play or where we sit. Lastly, we strive to enable the impossible because patients are counting on us. We are not afraid to take risks to unlock innovation and advance scientific discoveries.
These values are the foundation of our work, empowering us to make a real difference, every day.
Position Title: Associate Director, Drug Substance Development
Department: Technical Operations - Drug Substance
Reports To: Vice President, Head of Drug Substance
Location: Princeton, NJ – On-site 4 days per week (Mon to Thurs)
Job Overview
Kardigan Bio is looking for an Associate Director to join the Drug Substance team within the Technical Operations department. The Associate Director will be responsible for the implementation of oligonucleotide and small molecule manufacturing technologies, including cross-departmental collaboration to enable facility fit, development of process documentation (global guidance documents, process control strategies, process risk assessments, etc), inspection readiness, and technical regulatory submissions. This role will support clinical and commercial product lifecycle management, including authoring technical assessments and monitoring process performance including, but not limited to, continued process verification. The role collaborates across all CMC functional areas to ensure project advancement, rapid and best in class execution, and communication of challenges/opportunities.
Key Responsibilities
Responsibilities Include, But Are Not Limited To, The Following
- Lead process and technology transfers, change management, and technical process support clinical and commercial Oligonucleotide and small molecule products.
- Owner of process control strategies including process risk assessments and process validation.
- Comprehensive data analyses using historical process experience and characterization studies to identify trends in process performance and drive changes in the process control strategy and risk assessments
- Lead production related investigations, ensuring compliance with internal standards and regulatory requirements.
- Own process validation (PV) reports including process monitoring of manufacturing processes to understand process capability and performance drift over time.
- Provide necessary technical analysis to support impact assessments and investigations.
- Develop, execute and implement manufacturing process improvement activities in accordance with the overall life cycle plan for the product
- Share operational and process learnings with the rest of the manufacturing network
Basic Qualifications
- MSc, or BSc in Chemistry or equivalent with minimum of 10+ years of relevant experience. Familiarity with oligonucleotide/small molecule processes and cGMPs is preferred.
- Ability to effectively lead cross functional teams, meet deadlines, and prioritize responsibilities.
- Ability to assess risk and develop contingency plans for process risks.
- Experienced with small molecule & oligonucleotides drug substance programs.
- Experienced in purifying and drying unit operations intended for oligonucleotide products, filtration, ultrafiltration and chromatography technologies
- Authored Technical Reports, Application Notes, Risk Assessments, & Protocols
- Cultivate/ managed relationships with external partners to drive business objective
- Experienced with Regulatory IND and NDA submissions
- Designed and deployed standard work tools for data collection and interpretation, Advanced data management and statistical analysis skillset
- Experience working in a self-driven, performance/results oriented, fast paced matrix environment.
- Excellent problem-solving skills, including issue resolution, root cause investigations and CAPAs.
- Able to manage time and elevate relevant issues to project lead and line management.
- Detail oriented with excellent verbal and written communication skills.
- Strong interpersonal and leadership skills to work with teams in different functions and organizations and CDMO’s.
Preferred Qualifications
- Experience with small molecule and/or oligonucleotides process characterization, control strategy, development and / or manufacturing.
- Supported NDA submission for small molecules and/or oligonucleotide programs.
- Experience with technology transfer in a manufacturing environment and PIP support.
- Proficiency utilizing MS Office products and working knowledge of statistical software JMP, Spotfire, Minitab)
- 10-15 years of experience in oligonucleotide or small molecule process development, MS&T, and/or manufacturing.
- Experience with commercial product support, i.e. post-marketing commitments, on-going validation and comparability.
- PhD in Organic chemistry